Search for Clinical Trial Results
Carcinoma, Small Cell - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma Condition: Small Cell Carcinoma Date: 2016-08-23 Interventions:
|
Recruiting |
Study Name: Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study Condition: Carcinoma, Small Cell Date: 2015-01-29 Interventions: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi VMAT plan to treat the whole bra |
Terminated |
Study Name: A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide Condition: Carcinoma, Small Cell Date: 2007-09-27 Interventions:
|
Completed |
Study Name: BI 2536 Second Line Monotherapy in SCLC Condition: Carcinoma, Small Cell Date: 2006-12-18 Interventions: Drug: BI 2536 |
Completed |
Study Name: Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Date: 2006-03-20 Interventions:
|
Recruiting |
Study Name: TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) Condition: Carcinoma, Small Cell Date: 2015-11-10 Interventions: Drug: ARQ197 Other Name: Tivantinib |
Completed |
Study Name: A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned Condition: Carcinoma, Small Cell Date: 2005-09-12 Interventions: Drug: Pemetrexed |
Completed |
Study Name: Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Date: 2005-08-03 Interventions: Procedure: External beam radiotherapy |
Recruiting |
Study Name: HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Lung Date: 2016-03-25 Interventions:
|
Terminated |
Study Name: Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) Condition: Carcinoma, Small Cell Date: 2006-05-09 Interventions: Drug: Bemiparin subcutaneous administration (sc) of Bemiparin (3,500 UI/day) for 26 weeks, starting on t |